The effects of Chinese herbal medicine in polycystic ovary syndrome (PCOS)

Not Applicable

Completed

• Conditions: Polycystic ovary syndrome; Nutritional, Metabolic, Endocrine; Polycystic ovarian syndrome

• Registration Number: ISRCTN31072075
• Lead Sponsor: niversity of Southampton (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-01-31
• Last Update Posted: 27 February 2017

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

1. Females aged 18-44
2. Present with oligomenorrhoea (irregular periods) defined as intervals between periods of >35 days and <200 days, OR with amenorrhoea (absence of periods), defined as intervals between periods of =200 days
3. Diagnosis of PCOS consistent with the Rotterdam criteria

Exclusion Criteria

1. Suffer from other causes of hyperandorgenism and menstrual irregularities e.g. thyroid or prolactin disorders, acromegaly, Cushing's syndrome
2. Are pregnant, or suspected to be pregnant
3. Are breastfeeding within 6 months of study start date
4. Are receiving treatments or medications prohibited for use during the study
5. History of liver or kidney pathologies
6. History of psychotic illness
7. Present with current and major depression
8. Current harmful and hazardous drinking
9. Allergies to herbal ingredients contained in the CHM treatments
10. Do not have the spoken or written language skills to take part owing to study assessments and materials being available only in English
11. Present with abnormal liver and/or kidney function

Study & Design

• Study Type: Interventional
• Study Design: Not specified